Publication | Closed Access

Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study

Hematological MalignancyLaboratory HematologyRandomized Multicenter StudyMedicineMalignant Blood DisorderImmunologyHematologyDose RequirementOncologyAplastic AnemiaIntravenous Iron